Geriatric Optimization Plan to Improve Survival in Older Adult Allogeneic Hematopoietic Cell Transplant Candidates, OTIS Study
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
Massachusetts General Hospital
Gamida Cell ltd
Prelude Therapeutics
Brown University
Center for International Blood and Marrow Transplant Research
Masonic Cancer Center, University of Minnesota
Janssen Research & Development, LLC
H. Lee Moffitt Cancer Center and Research Institute
National Institutes of Health Clinical Center (CC)
University of Arizona
Thomas Jefferson University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Institutes of Health Clinical Center (CC)
Asan Medical Center
Stanford University
Center for International Blood and Marrow Transplant Research
Massachusetts General Hospital
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
American Regent, Inc.
Masonic Cancer Center, University of Minnesota
Thomas Jefferson University
Thomas Jefferson University
Memorial Sloan Kettering Cancer Center
Washington University School of Medicine
National Cancer Institute (NCI)
Celgene
Ann & Robert H Lurie Children's Hospital of Chicago
Fred Hutchinson Cancer Center
City of Hope Medical Center
UNC Lineberger Comprehensive Cancer Center
Astellas Pharma Inc
Stanford University
GlaxoSmithKline
City of Hope Medical Center
St. Petersburg State Pavlov Medical University
University College, London
University of Chicago
Qianfoshan Hospital
City of Hope Medical Center
Ipsen
University Hospital, Basel, Switzerland
Gruppo Italiano Malattie EMatologiche dell'Adulto
City of Hope Medical Center
Stanford University
Beth Israel Deaconess Medical Center
Novo Nordisk A/S
Washington University School of Medicine
University of Nebraska